# Protagonist Therapeutics, Inc. (PTGX): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for Protagonist Therapeutics, Inc. (PTGX) is 66/100, ranked against 24,000+ stocks in 35 markets (Quality 79, Value 12, Momentum 69, each scored against its sector).

- StockRank: 66/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 79, Value 12, Momentum 69: each a 0-100 percentile within Healthcare.
- Position: #9,134 overall, #913 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 138.43 USD on 23 Oct 2026.
- Insider filings, last 180 days: directors sold USD 51.9M.

Source: https://moatmap.ai/stock/PTGX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker